Onconic Therapeutics Inc. (KOSDAQ:476060)
16,210
+440 (2.79%)
Nov 20, 2025, 3:30 PM KST
Onconic Therapeutics Revenue
Onconic Therapeutics had revenue of 19.21B KRW in the quarter ending September 30, 2025, with 867.06% growth. This brings the company's revenue in the last twelve months to 46.65B, up 529.90% year-over-year. In the year 2024, Onconic Therapeutics had annual revenue of 14.84B, down -29.53%.
Revenue (ttm)
46.65B
Revenue Growth
+529.90%
P/S Ratio
15.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
700.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.84B | -6.22B | -29.53% |
| Dec 31, 2023 | 21.06B | 20.96B | 22,064.25% |
| Dec 31, 2022 | 95.00M | 35.00M | 58.33% |
| Dec 31, 2021 | 60.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition